418 related articles for article (PubMed ID: 31778219)
21. Prevalence of anti-DFS70 autoantibodies in a Latin American cohort of patients with systemic lupus erythematosus and without autoimmune diseases.
Aragón CC; Posso-Osorio I; Puerta G; González JD; Naranjo JC; Echeverri A; Ortíz E; Nieto-Aristizábal I; Barrera MC; Ríos-Serna LJ; Tobón GJ
Clin Rheumatol; 2020 Jul; 39(7):2163-2169. PubMed ID: 32086623
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
Choi MY; Clarke AE; Urowitz M; Hanly J; St-Pierre Y; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Wallace DJ; Isenberg D; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Buyon JP; Costenbader KH; Fritzler MJ
Ann Rheum Dis; 2022 Aug; 81(8):1143-1150. PubMed ID: 35338033
[TBL] [Abstract][Full Text] [Related]
23. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
24. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
Front Immunol; 2019; 10():444. PubMed ID: 30915082
[TBL] [Abstract][Full Text] [Related]
27. Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset.
Sebastiani GD; Prevete I; Piga M; Iuliano A; Bettio S; Bortoluzzi A; Coladonato L; Tani C; Spinelli FR; Fineschi I; Mathieu A
Lupus; 2015 Oct; 24(12):1276-82. PubMed ID: 25979916
[TBL] [Abstract][Full Text] [Related]
28. Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity.
Emad Y; Gheita T; Darweesh H; Klooster P; Gamal R; Fathi H; El-Shaarawy N; Gamil M; Hawass M; El-Refai RM; Al-Hanafi H; Abd-Ellatif S; Ismail A; Rasker J
Reumatismo; 2018 Jul; 70(2):85-91. PubMed ID: 29976042
[TBL] [Abstract][Full Text] [Related]
29. Rare immunofluorescence patterns of autoantibodies on HEp-2 cells defined by ICAP identify different autoimmune diseases in the absence of associated specificities: a Spanish multicentre study.
Irure-Ventura J; Rodríguez C; Vergara-Prieto E; Vargas ML; Quirant B; Jurado A; Fernández-Pereira L; Martínez-Cáceres E; San José M; López-Hoyos M;
Rheumatology (Oxford); 2021 Aug; 60(8):3904-3912. PubMed ID: 33437990
[TBL] [Abstract][Full Text] [Related]
30. Analysis of immunity index and immunopathogenesis pattern of lupus nephritis patients.
Gao JX; Diao HL; Liu YQ; Lv M; Dong H; Zhang XM; Wang YN
J Biol Regul Homeost Agents; 2015; 29(1):201-6. PubMed ID: 25864759
[TBL] [Abstract][Full Text] [Related]
31. Anti-ENA profiles related with anti-SS-A/Ro. The detection of Ro52 and Ro60 according to the presence of SS-B/La, and ANA pattern and titer.
González DA; Rodríguez CC; Armas LM; Varela AR; Rodríguez IM; Duarte MT; de León AC
Immunol Lett; 2014 Sep; 161(1):6-12. PubMed ID: 24768604
[TBL] [Abstract][Full Text] [Related]
32. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
Tiao J; Feng R; Carr K; Okawa J; Werth VP
J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
[TBL] [Abstract][Full Text] [Related]
33. Retrospective analysis of the clinical significance of Ro52/TRIM21 antibody and specific antinuclear antibody patterns by indirect immunofluorescence.
Liu K; Liao Y; Li P; Shi J
J Pak Med Assoc; 2024 Feb; 74(2):236-242. PubMed ID: 38419219
[TBL] [Abstract][Full Text] [Related]
34. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
Choi MY; Clarke AE; St Pierre Y; Hanly JG; Urowitz MB; Romero-Diaz J; Gordon C; Bae SC; Bernatsky S; Wallace DJ; Merrill JT; Isenberg DA; Rahman A; Ginzler EM; Petri M; Bruce IN; Dooley MA; Fortin PR; Gladman DD; Sanchez-Guerrero J; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Alarcón GS; Manzi S; Nived O; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Stoll T; Buyon J; Mahler M; Fritzler MJ
Arthritis Care Res (Hoboken); 2019 Jul; 71(7):893-902. PubMed ID: 30044551
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems.
Wichainun R; Kasitanon N; Wangkaew S; Hongsongkiat S; Sukitawut W; Louthrenoo W
Asian Pac J Allergy Immunol; 2013 Dec; 31(4):292-8. PubMed ID: 24383972
[TBL] [Abstract][Full Text] [Related]
37. Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus.
Zeng Y; Zhang Y; Chen Q; Huang Q; Lin Y; Wang X; Wang JJ; Jiang L; Xiao Y
Lupus; 2021 May; 30(6):901-912. PubMed ID: 33622075
[TBL] [Abstract][Full Text] [Related]
38. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.
Olsen NJ; James JA; Arriens C; Ishimori ML; Wallace DJ; Kamen DL; Chong BF; Liao D; Chinchilli VM; Karp DR
Trials; 2018 Dec; 19(1):694. PubMed ID: 30572906
[TBL] [Abstract][Full Text] [Related]
39. Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.
Zeng Y; Lin Y; Wang X; Zhang Y; Peng F; Wang J; Jiang L; Liang S; Xiao Y
Clin Rheumatol; 2020 Sep; 39(9):2619-2629. PubMed ID: 32189150
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus.
Parodis I; Åkerström E; Sjöwall C; Sohrabian A; Jönsen A; Gomez A; Frodlund M; Zickert A; Bengtsson AA; Rönnelid J; Gunnarsson I
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
